Antibody Production Market Drivers and Opportunities - 2031
The Antibody Production Market is expected to register a CAGR of 12.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented based on Type, Device and End User. The global analysis is further broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Antibody Production Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antibody Production Market Segmentation
Type- Monoclonal
- Polyclonal
- Bioreactors
- Chromatography
- Consumables
- Biopharmaceutical/Pharmaceutical Companies
- Research & Academic Institutes
- Diagnostic Laboratories
Strategic Insights
Antibody Production Market Growth Drivers- Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases is driving the demand for therapeutic antibodies.
- Advancements in Biotechnology: Rapid advancements in biotechnology, including genetic engineering and recombinant DNA technology, are enabling the development of highly specific and potent therapeutic antibodies.
- Growing Pharmaceutical Research and Development: Extensive research and development activities in the pharmaceutical industry are fueling the need for antibodies as potential drug candidates.
- Personalized Medicine: The integration of personalized medicine approaches will enable the development of tailored antibody therapies based on individual patient genetics and tumor biology.
- Combination Therapies: The combination of antibody therapies with other treatment modalities, such as chemotherapy and immunotherapy, will enhance treatment efficacy and improve patient outcomes.
- Therapeutic Antibody Development: The development of novel therapeutic antibodies, such as bispecific antibodies and antibody-drug conjugates, will continue to drive market growth.
- Biosimilars: The development and commercialization of biosimilar antibody drugs can provide cost-effective alternatives to branded biologics.
- Emerging Markets: Developing countries with growing healthcare infrastructure and increasing healthcare expenditure offer significant growth opportunities for the antibody production market.
- Strategic Partnerships: Collaborating with pharmaceutical companies, biotechnology firms, and academic institutions can accelerate product development and market access.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antibody Production Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antibody Production Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Antibody Production Market is expected to grow at a CAGR of 12.5% between 2023-2031
The driving factors impacting the Antibody Production Market are: Rising Prevalence of Chronic Diseases, Advancements in Biotechnology
The future trends of the Antibody Production Market are: Personalized Medicine, Combination Therapies
The leading players in the Antibody Production Market are: Thermo Fisher Scientific Inc., Merck KGaA, GENERAL ELECTRIC Company, Eppendorf AG, Abcam plc., F. Hoffmann-La Roche Ltd, Enzo Life Sciences, Inc.,, Proteintech Group, Inc., Bio-Rad Laboratories, Inc., Novus Biologicals
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibody Production Market - By Type
1.3.2 Antibody Production Market - By Device
1.3.3 Antibody Production Market - By End User
1.3.4 Antibody Production Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIBODY PRODUCTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBODY PRODUCTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANTIBODY PRODUCTION MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBODY PRODUCTION - GLOBAL MARKET OVERVIEW
6.2. ANTIBODY PRODUCTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIBODY PRODUCTION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL
7.3.1. Overview
7.3.2. Monoclonal Market Forecast and Analysis
7.4. POLYCLONAL
7.4.1. Overview
7.4.2. Polyclonal Market Forecast and Analysis
8. ANTIBODY PRODUCTION MARKET - REVENUE AND FORECASTS TO 2028 - DEVICE
8.1. OVERVIEW
8.2. DEVICE MARKET FORECASTS AND ANALYSIS
8.3. BIOREACTORS
8.3.1. Overview
8.3.2. Bioreactors Market Forecast and Analysis
8.4. CHROMATOGRAPHY
8.4.1. Overview
8.4.2. Chromatography Market Forecast and Analysis
8.5. CONSUMABLES
8.5.1. Overview
8.5.2. Consumables Market Forecast and Analysis
9. ANTIBODY PRODUCTION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. BIOPHARMACEUTICAL/PHARMACEUTICAL COMPANIES
9.3.1. Overview
9.3.2. Biopharmaceutical/Pharmaceutical Companies Market Forecast and Analysis
9.4. RESEARCH & ACADEMIC INSTITUTES
9.4.1. Overview
9.4.2. Research & Academic Institutes Market Forecast and Analysis
9.5. DIAGNOSTIC LABORATORIES
9.5.1. Overview
9.5.2. Diagnostic Laboratories Market Forecast and Analysis
10. ANTIBODY PRODUCTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antibody Production Market Overview
10.1.2 North America Antibody Production Market Forecasts and Analysis
10.1.3 North America Antibody Production Market Forecasts and Analysis - By Type
10.1.4 North America Antibody Production Market Forecasts and Analysis - By Device
10.1.5 North America Antibody Production Market Forecasts and Analysis - By End User
10.1.6 North America Antibody Production Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antibody Production Market
10.1.6.1.1 United States Antibody Production Market by Type
10.1.6.1.2 United States Antibody Production Market by Device
10.1.6.1.3 United States Antibody Production Market by End User
10.1.6.2 Canada Antibody Production Market
10.1.6.2.1 Canada Antibody Production Market by Type
10.1.6.2.2 Canada Antibody Production Market by Device
10.1.6.2.3 Canada Antibody Production Market by End User
10.1.6.3 Mexico Antibody Production Market
10.1.6.3.1 Mexico Antibody Production Market by Type
10.1.6.3.2 Mexico Antibody Production Market by Device
10.1.6.3.3 Mexico Antibody Production Market by End User
10.2. EUROPE
10.2.1 Europe Antibody Production Market Overview
10.2.2 Europe Antibody Production Market Forecasts and Analysis
10.2.3 Europe Antibody Production Market Forecasts and Analysis - By Type
10.2.4 Europe Antibody Production Market Forecasts and Analysis - By Device
10.2.5 Europe Antibody Production Market Forecasts and Analysis - By End User
10.2.6 Europe Antibody Production Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antibody Production Market
10.2.6.1.1 Germany Antibody Production Market by Type
10.2.6.1.2 Germany Antibody Production Market by Device
10.2.6.1.3 Germany Antibody Production Market by End User
10.2.6.2 France Antibody Production Market
10.2.6.2.1 France Antibody Production Market by Type
10.2.6.2.2 France Antibody Production Market by Device
10.2.6.2.3 France Antibody Production Market by End User
10.2.6.3 Italy Antibody Production Market
10.2.6.3.1 Italy Antibody Production Market by Type
10.2.6.3.2 Italy Antibody Production Market by Device
10.2.6.3.3 Italy Antibody Production Market by End User
10.2.6.4 Spain Antibody Production Market
10.2.6.4.1 Spain Antibody Production Market by Type
10.2.6.4.2 Spain Antibody Production Market by Device
10.2.6.4.3 Spain Antibody Production Market by End User
10.2.6.5 United Kingdom Antibody Production Market
10.2.6.5.1 United Kingdom Antibody Production Market by Type
10.2.6.5.2 United Kingdom Antibody Production Market by Device
10.2.6.5.3 United Kingdom Antibody Production Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antibody Production Market Overview
10.3.2 Asia-Pacific Antibody Production Market Forecasts and Analysis
10.3.3 Asia-Pacific Antibody Production Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Antibody Production Market Forecasts and Analysis - By Device
10.3.5 Asia-Pacific Antibody Production Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Antibody Production Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antibody Production Market
10.3.6.1.1 Australia Antibody Production Market by Type
10.3.6.1.2 Australia Antibody Production Market by Device
10.3.6.1.3 Australia Antibody Production Market by End User
10.3.6.2 China Antibody Production Market
10.3.6.2.1 China Antibody Production Market by Type
10.3.6.2.2 China Antibody Production Market by Device
10.3.6.2.3 China Antibody Production Market by End User
10.3.6.3 India Antibody Production Market
10.3.6.3.1 India Antibody Production Market by Type
10.3.6.3.2 India Antibody Production Market by Device
10.3.6.3.3 India Antibody Production Market by End User
10.3.6.4 Japan Antibody Production Market
10.3.6.4.1 Japan Antibody Production Market by Type
10.3.6.4.2 Japan Antibody Production Market by Device
10.3.6.4.3 Japan Antibody Production Market by End User
10.3.6.5 South Korea Antibody Production Market
10.3.6.5.1 South Korea Antibody Production Market by Type
10.3.6.5.2 South Korea Antibody Production Market by Device
10.3.6.5.3 South Korea Antibody Production Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antibody Production Market Overview
10.4.2 Middle East and Africa Antibody Production Market Forecasts and Analysis
10.4.3 Middle East and Africa Antibody Production Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Antibody Production Market Forecasts and Analysis - By Device
10.4.5 Middle East and Africa Antibody Production Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Antibody Production Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antibody Production Market
10.4.6.1.1 South Africa Antibody Production Market by Type
10.4.6.1.2 South Africa Antibody Production Market by Device
10.4.6.1.3 South Africa Antibody Production Market by End User
10.4.6.2 Saudi Arabia Antibody Production Market
10.4.6.2.1 Saudi Arabia Antibody Production Market by Type
10.4.6.2.2 Saudi Arabia Antibody Production Market by Device
10.4.6.2.3 Saudi Arabia Antibody Production Market by End User
10.4.6.3 U.A.E Antibody Production Market
10.4.6.3.1 U.A.E Antibody Production Market by Type
10.4.6.3.2 U.A.E Antibody Production Market by Device
10.4.6.3.3 U.A.E Antibody Production Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antibody Production Market Overview
10.5.2 South and Central America Antibody Production Market Forecasts and Analysis
10.5.3 South and Central America Antibody Production Market Forecasts and Analysis - By Type
10.5.4 South and Central America Antibody Production Market Forecasts and Analysis - By Device
10.5.5 South and Central America Antibody Production Market Forecasts and Analysis - By End User
10.5.6 South and Central America Antibody Production Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antibody Production Market
10.5.6.1.1 Brazil Antibody Production Market by Type
10.5.6.1.2 Brazil Antibody Production Market by Device
10.5.6.1.3 Brazil Antibody Production Market by End User
10.5.6.2 Argentina Antibody Production Market
10.5.6.2.1 Argentina Antibody Production Market by Type
10.5.6.2.2 Argentina Antibody Production Market by Device
10.5.6.2.3 Argentina Antibody Production Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIBODY PRODUCTION MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENERAL ELECTRIC COMPANY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EPPENDORF AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABCAM PLC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ENZO LIFE SCIENCES, INC.,
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PROTEINTECH GROUP, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIO-RAD LABORATORIES, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVUS BIOLOGICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MERCK KGAA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Thermo Fisher Scientific Inc.
2. Merck KGaA
3. GENERAL ELECTRIC COMPANY
4. Eppendorf AG
5. Abcam plc.
6. F. Hoffmann-La Roche Ltd
7. Enzo Life Sciences, Inc.,
8. Proteintech Group, Inc.
9. Bio-Rad Laboratories, Inc.
10. Novus Biologicals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.